| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |